Technology
Health
Medical

BioSig

$6.75
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.21 (-3.02%) Today
-$0.21 (-3.02%) Today

Why Robinhood?

You can buy or sell BioSig and other stocks, options, ETFs, and crypto commission-free!

About

BioSig Technologies, Inc. operates as a medical device company. It engages in the development of proprietary biomedical signal processing technology platform to minimize noise and artifacts from cardiac recordings. Read More The company develops and designs the precise uninterrupted real-time evaluation of electrograms electrophysiology (EP) system which acquires, processes, and displays electrocardiogram and electrograms required during EP studies and ablation procedures. BioSig Technologies was founded by Lora Mikolaitis, Budimir S. Drakulic and Kenneth L. Londoner on February 24, 2009 and is headquartered in Los Angeles, CA. BSGM is listed on the OTCQB market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com).

Employees
20
Headquarters
Los Angeles, California
Founded
2009
Market Cap
117.41M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
96.24K
High Today
$6.99
Low Today
$6.67
Open Price
$6.99
Volume
29.69K
52 Week High
$7.32
52 Week Low
$1.43

Collections

Technology
Health
Medical
2018 IPO
US
North America

News

Simply Wall StMar 14

Did You Miss BioSig Technologies’s (NASDAQ:BSGM) 74% Share Price Gain?

One simple way to benefit from the stock market is to buy an index fund. But if you choose individual stocks with prowess, you can make superior returns. Just take a look at BioSig Technologies, Inc. (NASDAQ:BSGM), which is up 74%, over three years, soundly beating the market return of 39% (not including dividends). However, more recent returns haven’t been as impressive as that, with the stock returning just 57% in the last year. See our latest analysis for BioSig Technologies With zero revenue generated...

120
MarketBeatMar 11

Stock Price, News, & Analysis for BioSig Technologies

BioSig Technologies, Inc., a development stage medical device company, engages in developing a proprietary biomedical signal processing technology platform to extract information from physiologic signals. Its product is PURE (Precise Uninterrupted Real-time evaluation of Electrograms) EP System, a surface electrocardiogram and intracardiac multichannel recording and analysis system that acquires, processes, and displays electrocardiogram and electrograms required during electrophysiology studies and cathete...

3
Associated PressMar 8

BioSig Technologies to Present at the LD Micro Virtual Conference

This content is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation. This content is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation. Santa Monica, CA, March 08, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical device company developing a proprietary biomedical signal processing platform designed to add...

60

Earnings

Q3 2018
Q4 2018
Estimated
Actual
Expected Mar 18
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.